nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2C8—Paclitaxel—ovarian cancer	0.059	0.167	CbGbCtD
Bupropion—CYP2D6—Vinorelbine—ovarian cancer	0.0535	0.152	CbGbCtD
Bupropion—CYP3A4—Topotecan—ovarian cancer	0.0483	0.137	CbGbCtD
Bupropion—CYP2B6—Doxorubicin—ovarian cancer	0.042	0.119	CbGbCtD
Bupropion—CYP2C9—Paclitaxel—ovarian cancer	0.0411	0.117	CbGbCtD
Bupropion—CYP3A4—Vinorelbine—ovarian cancer	0.034	0.0966	CbGbCtD
Bupropion—CYP3A4—Paclitaxel—ovarian cancer	0.0239	0.0679	CbGbCtD
Bupropion—CYP2D6—Doxorubicin—ovarian cancer	0.0203	0.0575	CbGbCtD
Bupropion—CYP3A4—Docetaxel—ovarian cancer	0.0173	0.0491	CbGbCtD
Bupropion—CYP3A4—Doxorubicin—ovarian cancer	0.0129	0.0366	CbGbCtD
Bupropion—Fatigue—Paclitaxel—ovarian cancer	0.00024	0.000395	CcSEcCtD
Bupropion—Sweating—Epirubicin—ovarian cancer	0.00024	0.000394	CcSEcCtD
Bupropion—Pollakiuria—Doxorubicin—ovarian cancer	0.00024	0.000394	CcSEcCtD
Bupropion—Constipation—Paclitaxel—ovarian cancer	0.000238	0.000392	CcSEcCtD
Bupropion—Pain—Paclitaxel—ovarian cancer	0.000238	0.000392	CcSEcCtD
Bupropion—Confusional state—Docetaxel—ovarian cancer	0.000238	0.000392	CcSEcCtD
Bupropion—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000237	0.000389	CcSEcCtD
Bupropion—Anaphylactic shock—Docetaxel—ovarian cancer	0.000236	0.000389	CcSEcCtD
Bupropion—Oedema—Docetaxel—ovarian cancer	0.000236	0.000389	CcSEcCtD
Bupropion—Weight increased—Doxorubicin—ovarian cancer	0.000236	0.000388	CcSEcCtD
Bupropion—Epistaxis—Epirubicin—ovarian cancer	0.000236	0.000388	CcSEcCtD
Bupropion—Infection—Docetaxel—ovarian cancer	0.000235	0.000386	CcSEcCtD
Bupropion—Weight decreased—Doxorubicin—ovarian cancer	0.000235	0.000386	CcSEcCtD
Bupropion—Sinusitis—Epirubicin—ovarian cancer	0.000235	0.000386	CcSEcCtD
Bupropion—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000234	0.000385	CcSEcCtD
Bupropion—Pneumonia—Doxorubicin—ovarian cancer	0.000233	0.000382	CcSEcCtD
Bupropion—Shock—Docetaxel—ovarian cancer	0.000233	0.000382	CcSEcCtD
Bupropion—Nervous system disorder—Docetaxel—ovarian cancer	0.000232	0.000381	CcSEcCtD
Bupropion—Thrombocytopenia—Docetaxel—ovarian cancer	0.000231	0.00038	CcSEcCtD
Bupropion—Infestation NOS—Doxorubicin—ovarian cancer	0.000231	0.00038	CcSEcCtD
Bupropion—Infestation—Doxorubicin—ovarian cancer	0.000231	0.00038	CcSEcCtD
Bupropion—Tachycardia—Docetaxel—ovarian cancer	0.000231	0.000379	CcSEcCtD
Bupropion—Feeling abnormal—Paclitaxel—ovarian cancer	0.00023	0.000378	CcSEcCtD
Bupropion—Skin disorder—Docetaxel—ovarian cancer	0.00023	0.000377	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000229	0.000377	CcSEcCtD
Bupropion—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000228	0.000375	CcSEcCtD
Bupropion—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000227	0.000373	CcSEcCtD
Bupropion—Haemoglobin—Epirubicin—ovarian cancer	0.000226	0.000371	CcSEcCtD
Bupropion—Stomatitis—Doxorubicin—ovarian cancer	0.000225	0.000371	CcSEcCtD
Bupropion—Jaundice—Doxorubicin—ovarian cancer	0.000225	0.000371	CcSEcCtD
Bupropion—Anorexia—Docetaxel—ovarian cancer	0.000225	0.00037	CcSEcCtD
Bupropion—Rhinitis—Epirubicin—ovarian cancer	0.000225	0.00037	CcSEcCtD
Bupropion—Urinary tract infection—Doxorubicin—ovarian cancer	0.000225	0.00037	CcSEcCtD
Bupropion—Conjunctivitis—Doxorubicin—ovarian cancer	0.000225	0.00037	CcSEcCtD
Bupropion—Hepatitis—Epirubicin—ovarian cancer	0.000224	0.000369	CcSEcCtD
Bupropion—Haemorrhage—Epirubicin—ovarian cancer	0.000224	0.000369	CcSEcCtD
Bupropion—Hypoaesthesia—Epirubicin—ovarian cancer	0.000223	0.000367	CcSEcCtD
Bupropion—Pharyngitis—Epirubicin—ovarian cancer	0.000223	0.000366	CcSEcCtD
Bupropion—Sweating—Doxorubicin—ovarian cancer	0.000222	0.000365	CcSEcCtD
Bupropion—Urinary tract disorder—Epirubicin—ovarian cancer	0.000222	0.000364	CcSEcCtD
Bupropion—Urticaria—Paclitaxel—ovarian cancer	0.000222	0.000364	CcSEcCtD
Bupropion—Oedema peripheral—Epirubicin—ovarian cancer	0.000221	0.000363	CcSEcCtD
Bupropion—Hypotension—Docetaxel—ovarian cancer	0.000221	0.000363	CcSEcCtD
Bupropion—Connective tissue disorder—Epirubicin—ovarian cancer	0.000221	0.000363	CcSEcCtD
Bupropion—Body temperature increased—Paclitaxel—ovarian cancer	0.00022	0.000362	CcSEcCtD
Bupropion—Abdominal pain—Paclitaxel—ovarian cancer	0.00022	0.000362	CcSEcCtD
Bupropion—Urethral disorder—Epirubicin—ovarian cancer	0.00022	0.000362	CcSEcCtD
Bupropion—Epistaxis—Doxorubicin—ovarian cancer	0.000218	0.000359	CcSEcCtD
Bupropion—Sinusitis—Doxorubicin—ovarian cancer	0.000217	0.000357	CcSEcCtD
Bupropion—Visual impairment—Epirubicin—ovarian cancer	0.000216	0.000356	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000215	0.000354	CcSEcCtD
Bupropion—Insomnia—Docetaxel—ovarian cancer	0.000214	0.000351	CcSEcCtD
Bupropion—Paraesthesia—Docetaxel—ovarian cancer	0.000212	0.000349	CcSEcCtD
Bupropion—Erythema multiforme—Epirubicin—ovarian cancer	0.000212	0.000349	CcSEcCtD
Bupropion—Dyspnoea—Docetaxel—ovarian cancer	0.000211	0.000346	CcSEcCtD
Bupropion—Somnolence—Docetaxel—ovarian cancer	0.00021	0.000345	CcSEcCtD
Bupropion—Eye disorder—Epirubicin—ovarian cancer	0.00021	0.000345	CcSEcCtD
Bupropion—Tinnitus—Epirubicin—ovarian cancer	0.000209	0.000344	CcSEcCtD
Bupropion—Haemoglobin—Doxorubicin—ovarian cancer	0.000209	0.000343	CcSEcCtD
Bupropion—Flushing—Epirubicin—ovarian cancer	0.000208	0.000342	CcSEcCtD
Bupropion—Cardiac disorder—Epirubicin—ovarian cancer	0.000208	0.000342	CcSEcCtD
Bupropion—Rhinitis—Doxorubicin—ovarian cancer	0.000208	0.000342	CcSEcCtD
Bupropion—Dyspepsia—Docetaxel—ovarian cancer	0.000208	0.000342	CcSEcCtD
Bupropion—Haemorrhage—Doxorubicin—ovarian cancer	0.000208	0.000341	CcSEcCtD
Bupropion—Hepatitis—Doxorubicin—ovarian cancer	0.000208	0.000341	CcSEcCtD
Bupropion—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000207	0.00034	CcSEcCtD
Bupropion—Pharyngitis—Doxorubicin—ovarian cancer	0.000206	0.000339	CcSEcCtD
Bupropion—Decreased appetite—Docetaxel—ovarian cancer	0.000205	0.000338	CcSEcCtD
Bupropion—Hypersensitivity—Paclitaxel—ovarian cancer	0.000205	0.000338	CcSEcCtD
Bupropion—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000205	0.000337	CcSEcCtD
Bupropion—Oedema peripheral—Doxorubicin—ovarian cancer	0.000205	0.000336	CcSEcCtD
Bupropion—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000204	0.000335	CcSEcCtD
Bupropion—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000204	0.000335	CcSEcCtD
Bupropion—Fatigue—Docetaxel—ovarian cancer	0.000204	0.000335	CcSEcCtD
Bupropion—Angiopathy—Epirubicin—ovarian cancer	0.000204	0.000335	CcSEcCtD
Bupropion—Urethral disorder—Doxorubicin—ovarian cancer	0.000204	0.000335	CcSEcCtD
Bupropion—Immune system disorder—Epirubicin—ovarian cancer	0.000203	0.000333	CcSEcCtD
Bupropion—Mediastinal disorder—Epirubicin—ovarian cancer	0.000202	0.000333	CcSEcCtD
Bupropion—Pain—Docetaxel—ovarian cancer	0.000202	0.000332	CcSEcCtD
Bupropion—Constipation—Docetaxel—ovarian cancer	0.000202	0.000332	CcSEcCtD
Bupropion—Chills—Epirubicin—ovarian cancer	0.000201	0.000331	CcSEcCtD
Bupropion—Arrhythmia—Epirubicin—ovarian cancer	0.0002	0.00033	CcSEcCtD
Bupropion—Visual impairment—Doxorubicin—ovarian cancer	0.0002	0.000329	CcSEcCtD
Bupropion—Asthenia—Paclitaxel—ovarian cancer	0.0002	0.000329	CcSEcCtD
Bupropion—Alopecia—Epirubicin—ovarian cancer	0.000198	0.000326	CcSEcCtD
Bupropion—Pruritus—Paclitaxel—ovarian cancer	0.000197	0.000324	CcSEcCtD
Bupropion—Mental disorder—Epirubicin—ovarian cancer	0.000197	0.000323	CcSEcCtD
Bupropion—Erythema multiforme—Doxorubicin—ovarian cancer	0.000196	0.000323	CcSEcCtD
Bupropion—Malnutrition—Epirubicin—ovarian cancer	0.000195	0.000321	CcSEcCtD
Bupropion—Feeling abnormal—Docetaxel—ovarian cancer	0.000195	0.00032	CcSEcCtD
Bupropion—Eye disorder—Doxorubicin—ovarian cancer	0.000194	0.000319	CcSEcCtD
Bupropion—Tinnitus—Doxorubicin—ovarian cancer	0.000194	0.000318	CcSEcCtD
Bupropion—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000193	0.000318	CcSEcCtD
Bupropion—Flushing—Doxorubicin—ovarian cancer	0.000193	0.000317	CcSEcCtD
Bupropion—Cardiac disorder—Doxorubicin—ovarian cancer	0.000193	0.000317	CcSEcCtD
Bupropion—Flatulence—Epirubicin—ovarian cancer	0.000193	0.000316	CcSEcCtD
Bupropion—Tension—Epirubicin—ovarian cancer	0.000192	0.000315	CcSEcCtD
Bupropion—Dysgeusia—Epirubicin—ovarian cancer	0.000191	0.000315	CcSEcCtD
Bupropion—Diarrhoea—Paclitaxel—ovarian cancer	0.000191	0.000314	CcSEcCtD
Bupropion—Nervousness—Epirubicin—ovarian cancer	0.00019	0.000312	CcSEcCtD
Bupropion—Back pain—Epirubicin—ovarian cancer	0.000189	0.000311	CcSEcCtD
Bupropion—Angiopathy—Doxorubicin—ovarian cancer	0.000188	0.00031	CcSEcCtD
Bupropion—Muscle spasms—Epirubicin—ovarian cancer	0.000188	0.000309	CcSEcCtD
Bupropion—Immune system disorder—Doxorubicin—ovarian cancer	0.000188	0.000308	CcSEcCtD
Bupropion—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000187	0.000308	CcSEcCtD
Bupropion—Body temperature increased—Docetaxel—ovarian cancer	0.000187	0.000307	CcSEcCtD
Bupropion—Abdominal pain—Docetaxel—ovarian cancer	0.000187	0.000307	CcSEcCtD
Bupropion—Chills—Doxorubicin—ovarian cancer	0.000186	0.000306	CcSEcCtD
Bupropion—Arrhythmia—Doxorubicin—ovarian cancer	0.000185	0.000305	CcSEcCtD
Bupropion—Dizziness—Paclitaxel—ovarian cancer	0.000184	0.000303	CcSEcCtD
Bupropion—Vision blurred—Epirubicin—ovarian cancer	0.000184	0.000303	CcSEcCtD
Bupropion—Alopecia—Doxorubicin—ovarian cancer	0.000183	0.000302	CcSEcCtD
Bupropion—Mental disorder—Doxorubicin—ovarian cancer	0.000182	0.000299	CcSEcCtD
Bupropion—Ill-defined disorder—Epirubicin—ovarian cancer	0.000181	0.000298	CcSEcCtD
Bupropion—Malnutrition—Doxorubicin—ovarian cancer	0.000181	0.000297	CcSEcCtD
Bupropion—Anaemia—Epirubicin—ovarian cancer	0.000181	0.000297	CcSEcCtD
Bupropion—Agitation—Epirubicin—ovarian cancer	0.00018	0.000295	CcSEcCtD
Bupropion—Flatulence—Doxorubicin—ovarian cancer	0.000178	0.000293	CcSEcCtD
Bupropion—Tension—Doxorubicin—ovarian cancer	0.000177	0.000292	CcSEcCtD
Bupropion—Vomiting—Paclitaxel—ovarian cancer	0.000177	0.000292	CcSEcCtD
Bupropion—Dysgeusia—Doxorubicin—ovarian cancer	0.000177	0.000291	CcSEcCtD
Bupropion—Malaise—Epirubicin—ovarian cancer	0.000176	0.00029	CcSEcCtD
Bupropion—Rash—Paclitaxel—ovarian cancer	0.000176	0.000289	CcSEcCtD
Bupropion—Dermatitis—Paclitaxel—ovarian cancer	0.000176	0.000289	CcSEcCtD
Bupropion—Nervousness—Doxorubicin—ovarian cancer	0.000176	0.000289	CcSEcCtD
Bupropion—Vertigo—Epirubicin—ovarian cancer	0.000176	0.000289	CcSEcCtD
Bupropion—Syncope—Epirubicin—ovarian cancer	0.000175	0.000288	CcSEcCtD
Bupropion—Leukopenia—Epirubicin—ovarian cancer	0.000175	0.000287	CcSEcCtD
Bupropion—Back pain—Doxorubicin—ovarian cancer	0.000175	0.000287	CcSEcCtD
Bupropion—Headache—Paclitaxel—ovarian cancer	0.000175	0.000287	CcSEcCtD
Bupropion—Hypersensitivity—Docetaxel—ovarian cancer	0.000174	0.000286	CcSEcCtD
Bupropion—Muscle spasms—Doxorubicin—ovarian cancer	0.000174	0.000286	CcSEcCtD
Bupropion—Palpitations—Epirubicin—ovarian cancer	0.000173	0.000284	CcSEcCtD
Bupropion—Loss of consciousness—Epirubicin—ovarian cancer	0.000172	0.000282	CcSEcCtD
Bupropion—Cough—Epirubicin—ovarian cancer	0.00017	0.00028	CcSEcCtD
Bupropion—Vision blurred—Doxorubicin—ovarian cancer	0.00017	0.00028	CcSEcCtD
Bupropion—Asthenia—Docetaxel—ovarian cancer	0.00017	0.000279	CcSEcCtD
Bupropion—Convulsion—Epirubicin—ovarian cancer	0.000169	0.000278	CcSEcCtD
Bupropion—Hypertension—Epirubicin—ovarian cancer	0.000169	0.000277	CcSEcCtD
Bupropion—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000168	0.000276	CcSEcCtD
Bupropion—Pruritus—Docetaxel—ovarian cancer	0.000167	0.000275	CcSEcCtD
Bupropion—Anaemia—Doxorubicin—ovarian cancer	0.000167	0.000275	CcSEcCtD
Bupropion—Chest pain—Epirubicin—ovarian cancer	0.000166	0.000273	CcSEcCtD
Bupropion—Arthralgia—Epirubicin—ovarian cancer	0.000166	0.000273	CcSEcCtD
Bupropion—Myalgia—Epirubicin—ovarian cancer	0.000166	0.000273	CcSEcCtD
Bupropion—Agitation—Doxorubicin—ovarian cancer	0.000166	0.000273	CcSEcCtD
Bupropion—Anxiety—Epirubicin—ovarian cancer	0.000166	0.000272	CcSEcCtD
Bupropion—Nausea—Paclitaxel—ovarian cancer	0.000166	0.000272	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000165	0.000272	CcSEcCtD
Bupropion—Discomfort—Epirubicin—ovarian cancer	0.000164	0.00027	CcSEcCtD
Bupropion—Malaise—Doxorubicin—ovarian cancer	0.000163	0.000268	CcSEcCtD
Bupropion—Dry mouth—Epirubicin—ovarian cancer	0.000163	0.000267	CcSEcCtD
Bupropion—Vertigo—Doxorubicin—ovarian cancer	0.000162	0.000267	CcSEcCtD
Bupropion—Syncope—Doxorubicin—ovarian cancer	0.000162	0.000266	CcSEcCtD
Bupropion—Leukopenia—Doxorubicin—ovarian cancer	0.000162	0.000266	CcSEcCtD
Bupropion—Diarrhoea—Docetaxel—ovarian cancer	0.000162	0.000266	CcSEcCtD
Bupropion—Confusional state—Epirubicin—ovarian cancer	0.000161	0.000264	CcSEcCtD
Bupropion—Palpitations—Doxorubicin—ovarian cancer	0.00016	0.000263	CcSEcCtD
Bupropion—Oedema—Epirubicin—ovarian cancer	0.000159	0.000262	CcSEcCtD
Bupropion—Anaphylactic shock—Epirubicin—ovarian cancer	0.000159	0.000262	CcSEcCtD
Bupropion—Loss of consciousness—Doxorubicin—ovarian cancer	0.000159	0.000261	CcSEcCtD
Bupropion—Infection—Epirubicin—ovarian cancer	0.000158	0.00026	CcSEcCtD
Bupropion—Cough—Doxorubicin—ovarian cancer	0.000158	0.000259	CcSEcCtD
Bupropion—Shock—Epirubicin—ovarian cancer	0.000157	0.000258	CcSEcCtD
Bupropion—Convulsion—Doxorubicin—ovarian cancer	0.000157	0.000257	CcSEcCtD
Bupropion—Nervous system disorder—Epirubicin—ovarian cancer	0.000156	0.000257	CcSEcCtD
Bupropion—Dizziness—Docetaxel—ovarian cancer	0.000156	0.000257	CcSEcCtD
Bupropion—Thrombocytopenia—Epirubicin—ovarian cancer	0.000156	0.000257	CcSEcCtD
Bupropion—Hypertension—Doxorubicin—ovarian cancer	0.000156	0.000257	CcSEcCtD
Bupropion—Tachycardia—Epirubicin—ovarian cancer	0.000156	0.000256	CcSEcCtD
Bupropion—Skin disorder—Epirubicin—ovarian cancer	0.000155	0.000255	CcSEcCtD
Bupropion—Hyperhidrosis—Epirubicin—ovarian cancer	0.000154	0.000253	CcSEcCtD
Bupropion—Myalgia—Doxorubicin—ovarian cancer	0.000154	0.000253	CcSEcCtD
Bupropion—Chest pain—Doxorubicin—ovarian cancer	0.000154	0.000253	CcSEcCtD
Bupropion—Arthralgia—Doxorubicin—ovarian cancer	0.000154	0.000253	CcSEcCtD
Bupropion—Anxiety—Doxorubicin—ovarian cancer	0.000153	0.000252	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000153	0.000251	CcSEcCtD
Bupropion—Discomfort—Doxorubicin—ovarian cancer	0.000152	0.00025	CcSEcCtD
Bupropion—Anorexia—Epirubicin—ovarian cancer	0.000152	0.00025	CcSEcCtD
Bupropion—Dry mouth—Doxorubicin—ovarian cancer	0.000151	0.000247	CcSEcCtD
Bupropion—Vomiting—Docetaxel—ovarian cancer	0.00015	0.000247	CcSEcCtD
Bupropion—Rash—Docetaxel—ovarian cancer	0.000149	0.000245	CcSEcCtD
Bupropion—Hypotension—Epirubicin—ovarian cancer	0.000149	0.000245	CcSEcCtD
Bupropion—Dermatitis—Docetaxel—ovarian cancer	0.000149	0.000245	CcSEcCtD
Bupropion—Confusional state—Doxorubicin—ovarian cancer	0.000149	0.000245	CcSEcCtD
Bupropion—Headache—Docetaxel—ovarian cancer	0.000148	0.000243	CcSEcCtD
Bupropion—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000148	0.000243	CcSEcCtD
Bupropion—Oedema—Doxorubicin—ovarian cancer	0.000148	0.000243	CcSEcCtD
Bupropion—Infection—Doxorubicin—ovarian cancer	0.000147	0.000241	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000145	0.000239	CcSEcCtD
Bupropion—Shock—Doxorubicin—ovarian cancer	0.000145	0.000239	CcSEcCtD
Bupropion—Nervous system disorder—Doxorubicin—ovarian cancer	0.000145	0.000238	CcSEcCtD
Bupropion—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000144	0.000237	CcSEcCtD
Bupropion—Insomnia—Epirubicin—ovarian cancer	0.000144	0.000237	CcSEcCtD
Bupropion—Tachycardia—Doxorubicin—ovarian cancer	0.000144	0.000237	CcSEcCtD
Bupropion—Skin disorder—Doxorubicin—ovarian cancer	0.000143	0.000236	CcSEcCtD
Bupropion—Paraesthesia—Epirubicin—ovarian cancer	0.000143	0.000235	CcSEcCtD
Bupropion—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000143	0.000234	CcSEcCtD
Bupropion—Dyspnoea—Epirubicin—ovarian cancer	0.000142	0.000234	CcSEcCtD
Bupropion—Somnolence—Epirubicin—ovarian cancer	0.000142	0.000233	CcSEcCtD
Bupropion—Anorexia—Doxorubicin—ovarian cancer	0.000141	0.000231	CcSEcCtD
Bupropion—Nausea—Docetaxel—ovarian cancer	0.00014	0.000231	CcSEcCtD
Bupropion—Dyspepsia—Epirubicin—ovarian cancer	0.00014	0.000231	CcSEcCtD
Bupropion—Decreased appetite—Epirubicin—ovarian cancer	0.000139	0.000228	CcSEcCtD
Bupropion—Hypotension—Doxorubicin—ovarian cancer	0.000138	0.000227	CcSEcCtD
Bupropion—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000138	0.000226	CcSEcCtD
Bupropion—Fatigue—Epirubicin—ovarian cancer	0.000137	0.000226	CcSEcCtD
Bupropion—Pain—Epirubicin—ovarian cancer	0.000136	0.000224	CcSEcCtD
Bupropion—Constipation—Epirubicin—ovarian cancer	0.000136	0.000224	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000134	0.000221	CcSEcCtD
Bupropion—Insomnia—Doxorubicin—ovarian cancer	0.000133	0.000219	CcSEcCtD
Bupropion—Paraesthesia—Doxorubicin—ovarian cancer	0.000132	0.000218	CcSEcCtD
Bupropion—Dyspnoea—Doxorubicin—ovarian cancer	0.000132	0.000216	CcSEcCtD
Bupropion—Feeling abnormal—Epirubicin—ovarian cancer	0.000131	0.000216	CcSEcCtD
Bupropion—Somnolence—Doxorubicin—ovarian cancer	0.000131	0.000216	CcSEcCtD
Bupropion—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00013	0.000214	CcSEcCtD
Bupropion—Dyspepsia—Doxorubicin—ovarian cancer	0.00013	0.000213	CcSEcCtD
Bupropion—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	0.00013	0.00328	CbGpPWpGaD
Bupropion—Decreased appetite—Doxorubicin—ovarian cancer	0.000128	0.000211	CcSEcCtD
Bupropion—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000127	0.000209	CcSEcCtD
Bupropion—Fatigue—Doxorubicin—ovarian cancer	0.000127	0.000209	CcSEcCtD
Bupropion—Urticaria—Epirubicin—ovarian cancer	0.000127	0.000208	CcSEcCtD
Bupropion—Constipation—Doxorubicin—ovarian cancer	0.000126	0.000207	CcSEcCtD
Bupropion—Pain—Doxorubicin—ovarian cancer	0.000126	0.000207	CcSEcCtD
Bupropion—Body temperature increased—Epirubicin—ovarian cancer	0.000126	0.000207	CcSEcCtD
Bupropion—Abdominal pain—Epirubicin—ovarian cancer	0.000126	0.000207	CcSEcCtD
Bupropion—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	0.000125	0.00317	CbGpPWpGaD
Bupropion—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000122	0.00309	CbGpPWpGaD
Bupropion—Feeling abnormal—Doxorubicin—ovarian cancer	0.000122	0.0002	CcSEcCtD
Bupropion—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000121	0.000198	CcSEcCtD
Bupropion—Hypersensitivity—Epirubicin—ovarian cancer	0.000117	0.000193	CcSEcCtD
Bupropion—Urticaria—Doxorubicin—ovarian cancer	0.000117	0.000193	CcSEcCtD
Bupropion—Body temperature increased—Doxorubicin—ovarian cancer	0.000117	0.000192	CcSEcCtD
Bupropion—Abdominal pain—Doxorubicin—ovarian cancer	0.000117	0.000192	CcSEcCtD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000116	0.00294	CbGpPWpGaD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000116	0.00294	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000115	0.0029	CbGpPWpGaD
Bupropion—Asthenia—Epirubicin—ovarian cancer	0.000114	0.000188	CcSEcCtD
Bupropion—Pruritus—Epirubicin—ovarian cancer	0.000113	0.000185	CcSEcCtD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000111	0.00281	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000111	0.00281	CbGpPWpGaD
Bupropion—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000111	0.00281	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.00011	0.00279	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00011	0.00279	CbGpPWpGaD
Bupropion—Diarrhoea—Epirubicin—ovarian cancer	0.000109	0.000179	CcSEcCtD
Bupropion—Hypersensitivity—Doxorubicin—ovarian cancer	0.000109	0.000179	CcSEcCtD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000107	0.0027	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000106	0.00269	CbGpPWpGaD
Bupropion—Asthenia—Doxorubicin—ovarian cancer	0.000106	0.000174	CcSEcCtD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000106	0.00268	CbGpPWpGaD
Bupropion—Dizziness—Epirubicin—ovarian cancer	0.000105	0.000173	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	0.000105	0.00266	CbGpPWpGaD
Bupropion—Pruritus—Doxorubicin—ovarian cancer	0.000104	0.000172	CcSEcCtD
Bupropion—Vomiting—Epirubicin—ovarian cancer	0.000101	0.000167	CcSEcCtD
Bupropion—Diarrhoea—Doxorubicin—ovarian cancer	0.000101	0.000166	CcSEcCtD
Bupropion—Rash—Epirubicin—ovarian cancer	0.000101	0.000165	CcSEcCtD
Bupropion—Dermatitis—Epirubicin—ovarian cancer	0.0001	0.000165	CcSEcCtD
Bupropion—Headache—Epirubicin—ovarian cancer	9.99e-05	0.000164	CcSEcCtD
Bupropion—SLC6A3—Transmembrane transport of small molecules—AQP3—ovarian cancer	9.83e-05	0.00249	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	9.82e-05	0.00249	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	9.78e-05	0.00248	CbGpPWpGaD
Bupropion—Dizziness—Doxorubicin—ovarian cancer	9.76e-05	0.00016	CcSEcCtD
Bupropion—Nausea—Epirubicin—ovarian cancer	9.47e-05	0.000156	CcSEcCtD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	9.44e-05	0.00239	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.42e-05	0.00238	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	9.41e-05	0.00238	CbGpPWpGaD
Bupropion—Vomiting—Doxorubicin—ovarian cancer	9.38e-05	0.000154	CcSEcCtD
Bupropion—Rash—Doxorubicin—ovarian cancer	9.3e-05	0.000153	CcSEcCtD
Bupropion—Dermatitis—Doxorubicin—ovarian cancer	9.29e-05	0.000153	CcSEcCtD
Bupropion—Headache—Doxorubicin—ovarian cancer	9.24e-05	0.000152	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	9.02e-05	0.00228	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	8.96e-05	0.00227	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	8.84e-05	0.00224	CbGpPWpGaD
Bupropion—Nausea—Doxorubicin—ovarian cancer	8.76e-05	0.000144	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—CYP1B1—ovarian cancer	8.49e-05	0.00215	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.41e-05	0.00213	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP1B1—ovarian cancer	8.38e-05	0.00212	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP1B1—ovarian cancer	8.32e-05	0.00211	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP1B1—ovarian cancer	8.2e-05	0.00208	CbGpPWpGaD
Bupropion—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—ovarian cancer	8.06e-05	0.00204	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.89e-05	0.002	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.45e-05	0.00189	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.39e-05	0.00187	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	7.27e-05	0.00184	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	7.19e-05	0.00182	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	7.09e-05	0.00179	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—NME2—ovarian cancer	6.42e-05	0.00162	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	6.13e-05	0.00155	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	6.13e-05	0.00155	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	6e-05	0.00152	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.93e-05	0.0015	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP1B1—ovarian cancer	5.9e-05	0.00149	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	5.85e-05	0.00148	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP1B1—ovarian cancer	5.82e-05	0.00147	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	5.77e-05	0.00146	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—MAPK1—ovarian cancer	5.66e-05	0.00143	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.61e-05	0.00142	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.54e-05	0.0014	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.42e-05	0.00137	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NME2—ovarian cancer	5.18e-05	0.00131	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	5.1e-05	0.00129	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NME2—ovarian cancer	5.07e-05	0.00128	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	5.04e-05	0.00127	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	5e-05	0.00127	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.97e-05	0.00126	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	4.93e-05	0.00125	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.8e-05	0.00121	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	4.69e-05	0.00119	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	4.59e-05	0.00116	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	4.59e-05	0.00116	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	4.59e-05	0.00116	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—HRAS—ovarian cancer	4.54e-05	0.00115	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.51e-05	0.00114	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NME2—ovarian cancer	4.38e-05	0.00111	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	4.33e-05	0.0011	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.28e-05	0.00108	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYTB—ovarian cancer	4.14e-05	0.00105	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.86e-05	0.000977	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.86e-05	0.000976	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.81e-05	0.000963	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.79e-05	0.000959	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.72e-05	0.000941	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	3.68e-05	0.000933	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PPP1CC—ovarian cancer	3.61e-05	0.000915	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—BRIP1—ovarian cancer	3.61e-05	0.000915	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NME2—ovarian cancer	3.6e-05	0.000911	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.57e-05	0.000903	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NME2—ovarian cancer	3.57e-05	0.000903	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYTB—ovarian cancer	3.34e-05	0.000845	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYTB—ovarian cancer	3.27e-05	0.000827	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NME2—ovarian cancer	3.05e-05	0.000772	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.03e-05	0.000767	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.03e-05	0.000766	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PPP1CC—ovarian cancer	2.92e-05	0.000738	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—BRIP1—ovarian cancer	2.92e-05	0.000738	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.87e-05	0.000725	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PPP1CC—ovarian cancer	2.86e-05	0.000723	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—BRIP1—ovarian cancer	2.86e-05	0.000723	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYTB—ovarian cancer	2.82e-05	0.000715	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.76e-05	0.000699	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—MAPK1—ovarian cancer	2.73e-05	0.000692	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.59e-05	0.000655	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—BRIP1—ovarian cancer	2.47e-05	0.000625	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PPP1CC—ovarian cancer	2.47e-05	0.000625	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.47e-05	0.000624	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—YAP1—ovarian cancer	2.42e-05	0.000614	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NME2—ovarian cancer	2.35e-05	0.000596	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYTB—ovarian cancer	2.32e-05	0.000587	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYTB—ovarian cancer	2.3e-05	0.000582	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.25e-05	0.000569	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—HRAS—ovarian cancer	2.2e-05	0.000556	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.11e-05	0.000534	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PPP1CC—ovarian cancer	2.03e-05	0.000513	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—BRIP1—ovarian cancer	2.03e-05	0.000513	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PPP1CC—ovarian cancer	2.01e-05	0.000509	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—BRIP1—ovarian cancer	2.01e-05	0.000509	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—FASN—ovarian cancer	1.98e-05	0.0005	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYTB—ovarian cancer	1.96e-05	0.000497	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—YAP1—ovarian cancer	1.96e-05	0.000495	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SLC5A5—ovarian cancer	1.94e-05	0.000492	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.92e-05	0.000486	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—YAP1—ovarian cancer	1.92e-05	0.000485	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SLC2A1—ovarian cancer	1.88e-05	0.000475	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.8e-05	0.000456	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.8e-05	0.000455	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.72e-05	0.000435	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.72e-05	0.000435	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—YAP1—ovarian cancer	1.66e-05	0.000419	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.64e-05	0.000415	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.6e-05	0.000404	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—FASN—ovarian cancer	1.59e-05	0.000404	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SLC5A5—ovarian cancer	1.57e-05	0.000397	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—FASN—ovarian cancer	1.56e-05	0.000395	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.54e-05	0.000389	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYTB—ovarian cancer	1.52e-05	0.000384	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SLC2A1—ovarian cancer	1.51e-05	0.000383	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.48e-05	0.000376	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.48e-05	0.000375	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.46e-05	0.000371	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—TYMS—ovarian cancer	1.46e-05	0.000368	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP1B1—ovarian cancer	1.45e-05	0.000368	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.44e-05	0.000365	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.42e-05	0.00036	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—YAP1—ovarian cancer	1.36e-05	0.000344	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—FASN—ovarian cancer	1.35e-05	0.000342	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—YAP1—ovarian cancer	1.35e-05	0.000341	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.33e-05	0.000338	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.33e-05	0.000336	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.33e-05	0.000335	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.33e-05	0.000335	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.29e-05	0.000326	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.28e-05	0.000325	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.26e-05	0.000319	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.26e-05	0.000318	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.25e-05	0.000317	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.23e-05	0.000311	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.2e-05	0.000303	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—TYMS—ovarian cancer	1.17e-05	0.000297	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CAV1—ovarian cancer	1.17e-05	0.000297	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.17e-05	0.000297	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.17e-05	0.000297	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—YAP1—ovarian cancer	1.15e-05	0.000292	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—TYMS—ovarian cancer	1.15e-05	0.000291	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.14e-05	0.000289	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—FASN—ovarian cancer	1.11e-05	0.000281	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—FASN—ovarian cancer	1.1e-05	0.000278	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.09e-05	0.000276	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1.09e-05	0.000276	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.09e-05	0.000275	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.08e-05	0.000274	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CG—ovarian cancer	1.07e-05	0.00027	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SLC2A1—ovarian cancer	1.05e-05	0.000267	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.04e-05	0.000264	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.02e-05	0.000259	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.01e-05	0.000256	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.01e-05	0.000256	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1e-05	0.000254	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1e-05	0.000253	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—TYMS—ovarian cancer	9.94e-06	0.000252	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CAV1—ovarian cancer	9.47e-06	0.00024	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CD—ovarian cancer	9.39e-06	0.000238	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—FASN—ovarian cancer	9.39e-06	0.000238	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CAV1—ovarian cancer	9.27e-06	0.000235	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SLC5A5—ovarian cancer	9.24e-06	0.000234	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	8.95e-06	0.000227	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SLC2A1—ovarian cancer	8.92e-06	0.000226	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—YAP1—ovarian cancer	8.89e-06	0.000225	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	8.88e-06	0.000225	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.83e-06	0.000224	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.73e-06	0.000221	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CG—ovarian cancer	8.62e-06	0.000218	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP1B1—ovarian cancer	8.55e-06	0.000216	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CG—ovarian cancer	8.44e-06	0.000214	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ABCB1—ovarian cancer	8.31e-06	0.00021	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ABCB1—ovarian cancer	8.24e-06	0.000209	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CB—ovarian cancer	8.19e-06	0.000207	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—TYMS—ovarian cancer	8.16e-06	0.000207	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—TYMS—ovarian cancer	8.09e-06	0.000205	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CAV1—ovarian cancer	8.01e-06	0.000203	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.66e-06	0.000194	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	7.58e-06	0.000192	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CD—ovarian cancer	7.58e-06	0.000192	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.55e-06	0.000191	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CD—ovarian cancer	7.42e-06	0.000188	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CG—ovarian cancer	7.3e-06	0.000185	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—FASN—ovarian cancer	7.25e-06	0.000183	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SLC5A5—ovarian cancer	7.13e-06	0.00018	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTEN—ovarian cancer	7.08e-06	0.000179	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ABCB1—ovarian cancer	7.04e-06	0.000178	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—TYMS—ovarian cancer	6.92e-06	0.000175	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.88e-06	0.000174	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CB—ovarian cancer	6.61e-06	0.000167	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.6e-06	0.000167	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CAV1—ovarian cancer	6.58e-06	0.000167	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CAV1—ovarian cancer	6.52e-06	0.000165	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CB—ovarian cancer	6.47e-06	0.000164	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CD—ovarian cancer	6.42e-06	0.000162	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.23e-06	0.000158	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CG—ovarian cancer	5.99e-06	0.000152	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.94e-06	0.00015	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.85e-06	0.000148	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTEN—ovarian cancer	5.71e-06	0.000144	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CB—ovarian cancer	5.59e-06	0.000142	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTEN—ovarian cancer	5.59e-06	0.000142	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CAV1—ovarian cancer	5.57e-06	0.000141	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.44e-06	0.000138	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—TYMS—ovarian cancer	5.34e-06	0.000135	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.32e-06	0.000135	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CD—ovarian cancer	5.27e-06	0.000133	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CD—ovarian cancer	5.22e-06	0.000132	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CG—ovarian cancer	5.08e-06	0.000128	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CA—ovarian cancer	4.99e-06	0.000126	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTEN—ovarian cancer	4.83e-06	0.000122	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.59e-06	0.000116	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.55e-06	0.000115	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.46e-06	0.000113	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CAV1—ovarian cancer	4.3e-06	0.000109	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—AKT1—ovarian cancer	4.08e-06	0.000103	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CA—ovarian cancer	4.03e-06	0.000102	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTEN—ovarian cancer	3.97e-06	0.0001	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.94e-06	9.98e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTEN—ovarian cancer	3.93e-06	9.96e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.92e-06	9.92e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.89e-06	9.85e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.44e-06	8.72e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.41e-06	8.63e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTEN—ovarian cancer	3.36e-06	8.51e-05	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—AKT1—ovarian cancer	3.29e-06	8.33e-05	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—AKT1—ovarian cancer	3.22e-06	8.16e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3e-06	7.6e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.8e-06	7.08e-05	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—AKT1—ovarian cancer	2.79e-06	7.05e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.77e-06	7.02e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTEN—ovarian cancer	2.59e-06	6.57e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.37e-06	6e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—AKT1—ovarian cancer	2.29e-06	5.79e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—AKT1—ovarian cancer	2.27e-06	5.74e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—AKT1—ovarian cancer	1.94e-06	4.9e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.83e-06	4.63e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—AKT1—ovarian cancer	1.5e-06	3.78e-05	CbGpPWpGaD
